Go Deep
Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -32,744 | -5.0 | -7.14 | 9.72 | 611.40 |
| Oct 2026 | -32,744 | -5.1 | -7.14 | 9.72 | 609.56 |
| Oct 2026 | -32,766 | -5.1 | -7.16 | 9.72 | 611.55 |
| Oct 2026 | -32,699 | -5.0 | -7.09 | 9.72 | 604.28 |
| Oct 2026 | -32,710 | -5.0 | -7.10 | 9.72 | 605.88 |
| Oct 2026 | -32,688 | -5.0 | -7.08 | 9.72 | 603.98 |
| Oct 2026 | -32,688 | -5.0 | -7.08 | 9.72 | 602.49 |
| Oct 2026 | -32,688 | -5.0 | -7.08 | 9.72 | 601.27 |
Lifecore Biomedical, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | May 2025 |
|---|---|---|---|---|
| Revenue | 34,167,000.0 | 23,193,000.0 | 31,109,000.0 | 36,444,000.0 |
| Net Profit | -6,156,000.0 | -14,980,000.0 | -9,991,000.0 | -1,147,000.0 |
| EPS | -0.2 | -0.4 | -0.3 | -0.1 |
Lifecore Biomedical, Inc. Revenue & Profit: Last 4 Years
| Line Item | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|
| Revenue | 128,867,000.0 | 128,261,000.0 | 103,269,000.0 | 111,270,000.0 |
| Net Profit | -38,717,000.0 | 12,013,000.0 | -99,563,000.0 | -116,715,000.0 |
| EPS | -1.3 | 0.4 | -3.4 | -3.3 |
Lifecore Biomedical, Inc. Balance Sheet
| Line Item | Dec 2025 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|
| Total Assets | 232,177,000.0 | 239,342,000.0 | 253,960,000.0 | 253,545,000.0 | — |
| Total Liabilities | 246,379,000.0 | 238,006,000.0 | 242,645,000.0 | 257,775,000.0 | — |
| Total Equity | -14,202,000.0 | 1,336,000.0 | 11,315,000.0 | -4,230,000.0 | — |
Owes vs Owns
Lifecore Biomedical, Inc. owed $1.15 for every $1 it owned in Jun 2026, up from $1.02 in May 2023.
| Period | Jun 2026 | Dec 2025 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.15× | 1.06× | 0.99× | 0.96× | 1.02× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lifecore Biomedical, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 7.5%Receivables 14.6%Inventory 12.5%Fixed assets (tangible) 54.8%Intangible assets 6.0%Other assets 4.6%
How it's funded — Dec 2025
Long-term debt 55.0%Payables 2.4%Other liabilities 42.3%
| Line Item | Dec 2025 | May 2025 | May 2024 | May 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 17.5 | 8.3 | 8.5 | 19.1 |
| Receivables | 33.8 | 43.7 | 31.2 | 29.0 |
| Inventory | 29.1 | 32.3 | 40.0 | 40.8 |
| Fixed assets (tangible) | 127.3 | 129.0 | 149.2 | 138.7 |
| Intangible assets | 13.9 | 13.9 | 13.9 | 18.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 10.6 | 12.2 | 11.3 | 7.8 |
| Liabilities & equity | ||||
| Short-term debt | 0.8 | 3.4 | 0.9 | 0.6 |
| Long-term debt | 135.6 | 127.0 | 123.7 | 101.1 |
| Payables | 5.8 | 8.2 | 16.3 | 22.1 |
| Other liabilities | 104.2 | 99.3 | 101.6 | 134.0 |
| Shareholders' equity | -14.2 | 1.3 | 11.3 | -4.2 |
| Net tangible assets | -28.1 | -12.5 | -2.6 | -22.3 |
Lifecore Biomedical, Inc. Cash Flow
| Line Item | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|
| Operating Activities | -206,000.0 | 257,000.0 | -17,441,000.0 | -22,593,000.0 |
| Investing Activities | -6,415,000.0 | -18,395,000.0 | -4,811,000.0 | 79,962,000.0 |
| Financing Activities | 6,424,000.0 | 7,509,000.0 | 39,700,000.0 | -57,021,000.0 |